← 返回资讯屏轩教育 · 行业资讯

A-Level生物 血糖调节 糖尿病机制 | A-Level Biology: Blood Glucose Regulation and Diabetes Mechanisms

2026-07-08 21:40 · 本文部分内容由AI辅助创作

A-Level生物 血糖调节 糖尿病机制

1. 稳态与血糖 Homeostasis and Blood Glucose

稳态是生物体维持内部环境相对稳定的能力,是生理学的核心概念。血糖浓度是人体最严格调控的生理参数之一:正常空腹血糖范围为4.0-5.4 mmol/L,餐后通常不超过7.8 mmol/L。偏离这一范围会导致严重的病理后果:低血糖(hypoglycaemia)可引起意识模糊和昏迷,而持续高血糖(hyperglycaemia)是糖尿病的标志,长期可损伤血管、神经和器官。血糖的精确调控依赖于多种激素的协同作用,其中胰岛素和胰高血糖素是最关键的两种。Homeostasis refers to the ability of an organism to maintain a relatively stable internal environment, a core concept in physiology. Blood glucose concentration is one of the most tightly regulated physiological parameters: the normal fasting range is 4.0-5.4 mmol/L, and postprandial levels typically do not exceed 7.8 mmol/L. Deviations lead to severe pathological consequences: hypoglycaemia can cause confusion and coma, while sustained hyperglycaemia is the hallmark of diabetes mellitus and can damage blood vessels, nerves, and organs over time. The precise regulation of blood glucose relies on the coordinated action of multiple hormones, with insulin and glucagon being the two most critical.

2. 胰腺与胰岛 The Pancreas and Islets of Langerhans

胰腺是一个兼具外分泌和内分泌功能的腺体器官,位于胃的后方。其外分泌部分分泌消化酶进入十二指肠,而内分泌功能由胰岛(Islets of Langerhans)执行。胰岛是散布在胰腺组织中的微小细胞团,约占胰腺总质量的1-2%,但在人类胰腺中数量超过一百万。每个胰岛包含多种内分泌细胞类型:α细胞(alpha cells)分泌胰高血糖素,β细胞(beta cells)分泌胰岛素,δ细胞(delta cells)分泌生长抑素。α细胞约占胰岛细胞的20%,β细胞约占70%。β细胞聚集在胰岛中央,而α细胞分布在周边区域。这种空间组织有助于旁分泌调控:胰岛素可以局部抑制胰高血糖素的分泌,反之亦然。The pancreas is a glandular organ with both exocrine and endocrine functions, located behind the stomach. Its exocrine portion secretes digestive enzymes into the duodenum, while the endocrine function is performed by the Islets of Langerhans. These are tiny clusters of cells scattered throughout the pancreatic tissue, comprising about 1-2% of total pancreatic mass but numbering over one million in the human pancreas. Each islet contains multiple endocrine cell types: alpha cells secrete glucagon, beta cells secrete insulin, and delta cells secrete somatostatin. Alpha cells account for approximately 20% of islet cells, while beta cells constitute about 70%. Beta cells cluster in the centre of the islet, while alpha cells are distributed around the periphery. This spatial organisation facilitates paracrine regulation: insulin can locally suppress glucagon secretion and vice versa.

3. 胰岛素的分泌与作用机制 Insulin: Secretion and Mechanism of Action

胰岛素是一种由51个氨基酸组成的肽类激素,由β细胞合成。其分泌受血糖浓度的直接调控。当血糖升高时(如进食后),葡萄糖通过GLUT2转运蛋白进入β细胞,经糖酵解和氧化磷酸化产生ATP。ATP浓度的升高导致ATP敏感性钾通道(KATP通道)关闭,细胞膜去极化,电压门控钙通道开放,钙离子内流触发含有胰岛素的囊泡与细胞膜融合,释放胰岛素进入血液。胰岛素通过作用于靶细胞(主要是肝细胞、肌肉细胞和脂肪细胞)来降低血糖。它与细胞膜上的胰岛素受体结合,激活受体酪氨酸激酶,引发细胞内信号级联反应,最终促使GLUT4葡萄糖转运蛋白从胞内囊泡转移到细胞膜上,增加葡萄糖的摄取。在肝细胞和肌肉细胞中,胰岛素还激活糖原合酶,促进葡萄糖转化为糖原储存(糖原生成);同时抑制糖原磷酸化酶,阻止糖原分解。Insulin is a peptide hormone composed of 51 amino acids, synthesised by beta cells. Its secretion is directly regulated by blood glucose concentration. When blood glucose rises (e.g., after a meal), glucose enters beta cells via GLUT2 transporters and undergoes glycolysis and oxidative phosphorylation to produce ATP. The rise in ATP concentration closes ATP-sensitive potassium channels (KATP channels), causing membrane depolarisation. Voltage-gated calcium channels then open, and the influx of calcium ions triggers insulin-containing vesicles to fuse with the cell membrane, releasing insulin into the bloodstream. Insulin lowers blood glucose by acting on target cells: primarily hepatocytes, muscle cells, and adipocytes. It binds to insulin receptors on the cell membrane, activating receptor tyrosine kinase and triggering intracellular signalling cascades that ultimately cause GLUT4 glucose transporters to translocate from intracellular vesicles to the plasma membrane, increasing glucose uptake. In hepatocytes and muscle cells, insulin also activates glycogen synthase, promoting the conversion of glucose to glycogen for storage (glycogenesis); simultaneously, it inhibits glycogen phosphorylase, preventing glycogen breakdown.

4. 胰高血糖素的作用 Glucagon and Its Actions

胰高血糖素是由α细胞分泌的29个氨基酸肽类激素,其作用与胰岛素基本相反。当血糖浓度下降至正常范围以下时(如在禁食、长时间运动或两餐之间),α细胞检测到低血糖并分泌胰高血糖素。胰高血糖素主要通过作用于肝脏来升高血糖。它与肝细胞膜上的胰高血糖素受体结合,激活腺苷酸环化酶,使cAMP浓度升高,进而激活蛋白激酶A(PKA)。PKA通过磷酸化级联反应激活糖原磷酸化酶,促进糖原分解为葡萄糖并释放入血。同时,胰高血糖素抑制糖原合酶,阻止糖原合成。在长时间禁食的情况下,当肝糖原储备耗尽后,胰高血糖素还促进糖异生:在肝脏中利用乳酸、氨基酸和甘油等非碳水化合物前体合成新的葡萄糖。胰高血糖素对骨骼肌没有直接的糖原分解作用,因为肌细胞不表达胰高血糖素受体。Glucagon is a 29-amino-acid peptide hormone secreted by alpha cells, and its actions are largely opposite to those of insulin. When blood glucose concentration drops below the normal range (e.g., during fasting, prolonged exercise, or between meals), alpha cells detect the low glucose level and secrete glucagon. Glucagon raises blood glucose primarily by acting on the liver. It binds to glucagon receptors on the hepatocyte membrane, activating adenylate cyclase, which increases cAMP concentration and subsequently activates protein kinase A (PKA). PKA triggers a phosphorylation cascade that activates glycogen phosphorylase, promoting glycogen breakdown into glucose for release into the bloodstream. Simultaneously, glucagon inhibits glycogen synthase, preventing glycogen synthesis. During prolonged fasting, once hepatic glycogen reserves are depleted, glucagon also promotes gluconeogenesis: the synthesis of new glucose in the liver from non-carbohydrate precursors such as lactate, amino acids, and glycerol. Glucagon has no direct glycogenolytic effect on skeletal muscle because muscle cells do not express glucagon receptors.

5. 负反馈调控系统 The Negative Feedback Control System

血糖调节是负反馈机制的经典范例。系统的核心是检测血糖浓度的传感器(α细胞和β细胞)和效应器(肝细胞、肌肉细胞和脂肪细胞)。当血糖升高偏离设定点时,β细胞分泌胰岛素,促进组织摄取葡萄糖并储存为糖原,使血糖下降回到正常范围。当血糖降低偏离设定点时,α细胞分泌胰高血糖素,促进肝糖原分解和糖异生,使血糖回升。这一负反馈回路确保血糖浓度在很窄的范围内波动。除了胰岛素和胰高血糖素的直接拮抗作用外,还有第二层调控:自主神经系统。交感神经激活(如在应激或运动中)通过肾上腺素作用于肝细胞的β受体,刺激糖原分解,快速动员葡萄糖。肾上腺素的这一作用与胰高血糖素协同,但通过不同的受体和信号通路实现。此外,生长激素和皮质醇等激素在长期应激中也参与血糖调节,但它们的作用更为缓慢和持续。Blood glucose regulation is a classic example of a negative feedback mechanism. At the core of the system are the sensors that detect glucose concentration (alpha and beta cells) and the effectors (hepatocytes, muscle cells, and adipocytes). When blood glucose rises above the set point, beta cells secrete insulin, promoting tissue glucose uptake and storage as glycogen, bringing glucose back down to the normal range. When blood glucose falls below the set point, alpha cells secrete glucagon, promoting hepatic glycogenolysis and gluconeogenesis, bringing glucose back up. This negative feedback loop ensures that blood glucose concentration fluctuates within a very narrow range. Beyond the direct antagonism of insulin and glucagon, there is a second layer of regulation: the autonomic nervous system. Sympathetic activation (e.g., during stress or exercise) stimulates glycogenolysis via adrenaline acting on beta-adrenergic receptors in hepatocytes, rapidly mobilising glucose. This adrenergic action synergises with glucagon but operates through different receptors and signalling pathways. Additionally, hormones such as growth hormone and cortisol participate in blood glucose regulation during prolonged stress, though their effects are slower and more sustained.

广告 / Sponsored

6. 1型糖尿病 Type 1 Diabetes Mellitus

1型糖尿病是一种自身免疫性疾病,患者的免疫系统错误地攻击并摧毁胰岛β细胞,导致胰岛素绝对缺乏。通常在儿童和青少年时期发病,因此曾被称为”青少年糖尿病”,但也可在成年后发生。β细胞的破坏是一个渐进的过程,当约80-90%的β细胞被摧毁后,临床症状开始显现。典型症状包括:多尿(polyuria,由于高血糖导致渗透性利尿)、多饮(polydipsia,因脱水而持续口渴)、体重下降(由于细胞无法利用葡萄糖,转而分解脂肪和蛋白质供能)和疲劳。如果不进行治疗,1型糖尿病患者会发展成糖尿病酮症酸中毒(DKA),这是一种危及生命的急性并发症:脂肪的过度分解产生大量酮体,导致代谢性酸中毒。治疗依赖于终身外源性胰岛素注射,通常采用基础-追加方案(basal-bolus regimen):长效胰岛素提供基础水平,短效胰岛素覆盖餐后血糖高峰。Type 1 diabetes mellitus is an autoimmune disease in which the immune system mistakenly attacks and destroys pancreatic beta cells, leading to an absolute deficiency of insulin. It typically manifests during childhood and adolescence, hence its historical name “juvenile diabetes,” though it can also develop in adulthood. Beta-cell destruction is a progressive process; clinical symptoms appear when approximately 80-90% of beta cells have been lost. Classic symptoms include: polyuria (osmotic diuresis caused by hyperglycaemia), polydipsia (persistent thirst due to dehydration), weight loss (cells cannot utilise glucose and instead break down fat and protein for energy), and fatigue. Without treatment, type 1 diabetes progresses to diabetic ketoacidosis (DKA), a life-threatening acute complication: excessive fat breakdown produces large quantities of ketone bodies, causing metabolic acidosis. Treatment relies on lifelong exogenous insulin injections, typically using a basal-bolus regimen: long-acting insulin provides a baseline level, while short-acting insulin covers postprandial glucose spikes.

7. 2型糖尿病 Type 2 Diabetes Mellitus

2型糖尿病占所有糖尿病病例的约90%,其病理基础是胰岛素抵抗和β细胞功能障碍。胰岛素抵抗是指靶细胞(肝细胞、肌肉细胞和脂肪细胞)对胰岛素的反应性下降:尽管胰岛素水平可能正常甚至升高,但细胞对葡萄糖的摄取效率显著降低。为了代偿,β细胞最初会分泌更多的胰岛素(高胰岛素血症),但随着时间的推移,β细胞逐渐衰竭,胰岛素分泌不足,导致血糖持续升高。2型糖尿病的危险因素包括肥胖(尤其是腹部肥胖)、久坐生活方式、不健康饮食、遗传易感性和年龄增长。肥胖是最大的可改变风险因素:过量的脂肪组织,特别是内脏脂肪,会释放游离脂肪酸和促炎细胞因子(如TNF-α和IL-6),干扰胰岛素信号通路。2型糖尿病的治疗通常始于生活方式干预(饮食控制和增加运动),随后可能需要口服降糖药如二甲双胍(metformin),它通过减少肝糖异生和增加外周组织对胰岛素的敏感性来降低血糖。在晚期病例中,可能也需要胰岛素治疗。Type 2 diabetes mellitus accounts for approximately 90% of all diabetes cases, with its pathological basis rooted in insulin resistance and beta-cell dysfunction. Insulin resistance means that target cells (hepatocytes, muscle cells, and adipocytes) show reduced responsiveness to insulin: despite normal or even elevated insulin levels, cellular glucose uptake efficiency is significantly impaired. As compensation, beta cells initially secrete more insulin (hyperinsulinaemia), but over time, they become progressively exhausted, insulin secretion becomes insufficient, and blood glucose remains persistently elevated. Risk factors for type 2 diabetes include obesity (particularly abdominal obesity), sedentary lifestyle, unhealthy diet, genetic predisposition, and advancing age. Obesity is the single largest modifiable risk factor: excess adipose tissue, especially visceral fat, releases free fatty acids and pro-inflammatory cytokines (such as TNF-alpha and IL-6) that interfere with insulin signalling pathways. Treatment for type 2 diabetes typically begins with lifestyle interventions (dietary control and increased physical activity), followed if necessary by oral hypoglycaemic agents such as metformin, which lowers blood glucose by reducing hepatic gluconeogenesis and increasing peripheral tissue insulin sensitivity. In advanced cases, insulin therapy may also be required.

8. 备考要点 Exam Tips

在A-Level考试中,血糖调节是高频考点,尤其常见于数据分析和实验设计题型。务必熟练掌握以下核心概念:首先,清晰区分胰岛素和胰高血糖素的来源细胞(β和α)、化学本质(均为肽类激素)、作用机制(信号转导通路)和靶器官(肝脏为核心)。其次,理解负反馈机制的具体运作方式:刺激是什么(血糖变化)、传感器在哪里(胰岛)、效应是什么(糖原生成/分解/糖异生)以及结果如何反馈(血糖恢复正常)。第三,熟悉两种糖尿病的病因学差异:1型是自身免疫导致的胰岛素绝对缺乏,2型是胰岛素抵抗伴随β细胞逐渐衰竭;二者的治疗策略也因此截然不同。考试中常见的陷阱题包括混淆糖原分解和糖异生的定义条件、误认为胰高血糖素直接作用于骨骼肌以及未能识别GLUT4转位在胰岛素信号中的关键地位。实验题可能涉及葡萄糖耐量测试曲线的解读:比较正常个体与糖尿病患者的血糖清除速率差异。In A-Level examinations, blood glucose regulation is a high-frequency topic, particularly common in data analysis and experimental design questions. Master the following core concepts thoroughly: first, clearly distinguish between insulin and glucagon in terms of their cell of origin (beta vs. alpha), chemical nature (both peptide hormones), mechanism of action (signal transduction pathways), and target organs (liver as the central hub). Second, understand how the negative feedback mechanism operates concretely: what the stimulus is (change in blood glucose), where the sensors are located (islets of Langerhans), what the effectors do (glycogenesis/glycogenolysis/gluconeogenesis), and how the outcome feeds back (blood glucose returns to normal). Third, be familiar with the aetiological differences between the two types of diabetes: type 1 involves an absolute insulin deficiency due to autoimmunity, while type 2 involves insulin resistance accompanied by progressive beta-cell exhaustion; their treatment strategies are therefore fundamentally different. Common exam pitfalls include confusing the conditions under which glycogenolysis and gluconeogenesis occur, mistakenly thinking that glucagon acts directly on skeletal muscle, and failing to recognise the critical role of GLUT4 translocation in insulin signalling. Experimental questions may involve interpreting glucose tolerance test curves: comparing the rates of glucose clearance between normal individuals and diabetic patients.

9. 总结 Summary

血糖调节是人类生理学中维持代谢稳态的关键机制,其精密的负反馈控制系统协调胰岛素和胰高血糖素的作用,将血糖维持在极窄的范围内。β细胞通过分泌胰岛素促进葡萄糖摄取和储存来降低血糖,而α细胞通过分泌胰高血糖素促进糖原分解和糖异生来升高血糖。这种拮抗作用的平衡一旦被打破,就会导致糖尿病等代谢性疾病。理解血糖调节的分子机制不仅对A-Level考试至关重要,也为进一步学习内分泌学、代谢疾病和临床医学奠定了坚实的基础。掌握胰岛素和胰高血糖素的信号通路、负反馈原理以及两种糖尿病的病理区别,是成功应对相关考题的关键。Blood glucose regulation is a vital mechanism in human physiology for maintaining metabolic homeostasis, with a precise negative feedback control system coordinating the actions of insulin and glucagon to keep blood glucose within an extremely narrow range. Beta cells lower blood glucose by secreting insulin to promote glucose uptake and storage, while alpha cells raise blood glucose by secreting glucagon to promote glycogenolysis and gluconeogenesis. When the balance of this antagonistic relationship is disrupted, metabolic diseases such as diabetes mellitus result. Understanding the molecular mechanisms of blood glucose regulation is not only essential for A-Level examinations but also provides a solid foundation for further studies in endocrinology, metabolic diseases, and clinical medicine. Mastering the signalling pathways of insulin and glucagon, the principles of negative feedback, and the pathological distinctions between the two types of diabetes is the key to successfully tackling related exam questions.

广告 / Sponsored
新Alevel生物OCR A复习题卡 New A-Level Biology OCR A Revision Quest…
生物 备考教辅 · 正版现货 · 与本文内容相关
查看详情 / View on Taobao参考价 ¥179.0

更多咨询请联系16621398022(同微信)

备考资讯每日更新,关注不错过
考纲变化 · 科目分析 · 学习方法
扫码关注公众号 tutorhao
在微信里长按二维码识别关注
或截图后用「扫一扫 → 相册」选择本图
公众号:tutorhao